Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) FCF Margin (2017 - 2020)

Cogent Biosciences has reported FCF Margin over the past 4 years, most recently at 3290.71% for Q3 2020.

  • Quarterly results put FCF Margin at 3290.71% for Q3 2020, down 229218.0% from a year ago — trailing twelve months through Jun 2021 was 13945.51% (down 1379945.0% YoY), and the annual figure for FY2025 was 8687.07%, changed.
  • FCF Margin for Q3 2020 was 3290.71% at Cogent Biosciences, down from 1576.52% in the prior quarter.
  • Over the last five years, FCF Margin for COGT hit a ceiling of 55.32% in Q4 2019 and a floor of 3290.71% in Q3 2020.
  • Median FCF Margin over the past 4 years was 362.88% (2018), compared with a mean of 633.4%.
  • Peak annual rise in FCF Margin hit 26638bps in 2020, while the deepest fall reached -229218bps in 2020.
  • Cogent Biosciences' FCF Margin stood at 272.21% in 2017, then increased by 13bps to 237.06% in 2018, then skyrocketed by 77bps to 55.32% in 2019, then plummeted by -5848bps to 3290.71% in 2020.
  • The last three reported values for FCF Margin were 3290.71% (Q3 2020), 1576.52% (Q2 2020), and 112.26% (Q1 2020) per Business Quant data.